Literature DB >> 29614878

Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis.

Dhamidhu Eratne1, Samantha M Loi2, Sarah Farrand1, Wendy Kelso1, Dennis Velakoulis1, Jeffrey Cl Looi3.   

Abstract

OBJECTIVES: To provide a clinical update for general psychiatrists on the assessment and diagnosis of Alzheimer's disease (AD), highlighting current issues regarding epidemiology, risk factors and pathophysiology from recent relevant research findings.
CONCLUSIONS: Psychiatrists can apply their skills and training in the diagnosis of AD, which is based upon a comprehensive assessment comprising history, investigations, and cognitive and functional assessment, guided by accepted diagnostic criteria.

Entities:  

Keywords:  Alzheimer’s disease; behavioural and psychological symptoms of dementia; diagnosis; neuropsychiatric symptoms; pathophysiology; psychiatry

Mesh:

Year:  2018        PMID: 29614878     DOI: 10.1177/1039856218762308

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  28 in total

Review 1.  Particulate matter and Alzheimer's disease: an intimate connection.

Authors:  Devin R O'Piela; George R Durisek; Yael-Natalie H Escobar; Amy R Mackos; Loren E Wold
Journal:  Trends Mol Med       Date:  2022-07-12       Impact factor: 15.272

Review 2.  Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Salomon Poliwoda; Rachel J Kaye; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

3.  Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.

Authors:  Hannah W Haddad; Garett W Malone; Nicholas J Comardelle; Arielle E Degueure; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-01-30

Review 4.  Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.

Authors:  Reza Majidazar; Erfan Rezazadeh-Gavgani; Saeed Sadigh-Eteghad; Amirreza Naseri
Journal:  Eur J Clin Pharmacol       Date:  2022-07-26       Impact factor: 3.064

Review 5.  Recent Synergy of Nanodiamonds: Role in Brain-Targeted Drug Delivery for the Management of Neurological Disorders.

Authors:  Deepali Bhogale; Farhan Mazahir; Awesh K Yadav
Journal:  Mol Neurobiol       Date:  2022-05-27       Impact factor: 5.682

6.  Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.

Authors:  Noorul Hasan; Saima Zameer; Abul Kalam Najmi; Suhel Parvez; Mohammad Shahar Yar; Mohd Akhtar
Journal:  Pharmacol Rep       Date:  2021-04-15       Impact factor: 3.024

7.  Optical coherence tomography angiography in preclinical Alzheimer's disease.

Authors:  Jacoba Alida van de Kreeke; Hoang-Ton Nguyen; Elles Konijnenberg; Jori Tomassen; Anouk den Braber; Mara Ten Kate; Maqsood Yaqub; Bart van Berckel; Adriaan A Lammertsma; Dorret I Boomsma; Stevie H Tan; Frank Verbraak; Pieter Jelle Visser
Journal:  Br J Ophthalmol       Date:  2019-05-22       Impact factor: 4.638

Review 8.  Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.

Authors:  Dubravka Svob Strac; Marcela Konjevod; Marina Sagud; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Barbara Vuic; Goran Simic; Vana Vukic; Ninoslav Mimica; Nela Pivac
Journal:  Pharmgenomics Pers Med       Date:  2021-05-28

9.  Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice.

Authors:  Meng Wang; Li-Rong Feng; Zi-Long Li; Kai-Ge Ma; Ke-Wei Chang; Xin-Lin Chen; Peng-Bo Yang; Sheng-Feng Ji; Yan-Bing Ma; Hua Han; John Bosco Ruganzua; Wei-Na Yang; Yi-Hua Qian
Journal:  J Neuroinflammation       Date:  2021-06-28       Impact factor: 8.322

10.  Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model.

Authors:  Qingyou Chen; Yue Yin; Li Li; Yanjiao Zhang; Wei He; Yan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-30       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.